ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
17 hedge funds and large institutions have $7.22M invested in Oncternal Therapeutics, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
17
Holding in Top 10
–
Calls
$1K
Puts
–
Top Buyers
| 1 | +$767K | |
| 2 | +$51K | |
| 3 | +$4K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.36K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$682 |
Top Sellers
| 1 | -$565K | |
| 2 | -$133K | |
| 3 | -$8.13K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$6K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$2.67K |